AYTU BioPharma
AYTU
AYTU
22 hedge funds and large institutions have $5.03M invested in AYTU BioPharma in 2023 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 8 increasing their positions, 6 reducing their positions, and 2 closing their positions.
Holders
22
Holders Change
–
Holders Change %
0%
% of All Funds
0.32%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
8
Reduced
6
Closed
2
Calls
$232K
Puts
–
Net Calls
+$232K
Net Calls Change
+$232K
Top Buyers
1 |
1
Geode Capital Management
Boston,
Massachusetts
|
$93.9K |
2 |
2
Vanguard Group
Malvern,
Pennsylvania
|
$77.4K |
3 |
3
Goldman Sachs
New York
|
$39.4K |
4 |
4
Renaissance Technologies
New York
|
$196K |
5 |
![]()
5
JPMorgan Chase & Co
New York
|
$19.4K |